Recently, during a WHO conference, international experts, regulators and policymakers examined how ashwagandha could be positioned within modern healthcare systems. While its growing global use and interest in adaptogenic properties were acknowledged, experts stressed the need for rigorous research, standardisation, pharmacovigilance and regulatory oversight.